NNN

Neurocrine

No trades
See on Supercharts

Key facts today

Neurocrine Biosciences Inc's phase 2 data for NBI-1117568 presented mixed results, demonstrating some efficacy; however, BMO Capital Markets reported no overall benefit from these trials.
Analyze the impactAnalyze the impact

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NBIX is featured.